Messerli SM - Search Results

1

Therapeutic Targeting of PTK7 is Cytotoxic in Atypical Teratoid Rhabdoid Tumors.

Messerli SM, Hoffman MM, Gnimpieba EZ, Bhardwaj RD. Messerli SM, et al. Mol Cancer Res. 2017 Aug;15(8):973-983. doi: 10.1158/1541-7786.MCR-16-0432. Epub 2017 Apr 25. Mol Cancer Res. 2017. PMID: 28442586 Free PMC article.

2

Analysis of Dual Class I Histone Deacetylase and Lysine Demethylase Inhibitor Domatinostat (4SC-202) on Growth and Cellular and Genomic Landscape of Atypical Teratoid/Rhabdoid.

Hoffman MM, Zylla JS, Bhattacharya S, Calar K, Hartman TW, Bhardwaj RD, Miskimins WK, de la Puente P, Gnimpieba EZ, Messerli SM. Hoffman MM, et al. Among authors: messerli sm. Cancers (Basel). 2020 Mar 23;12(3):756. doi: 10.3390/cancers12030756. Cancers (Basel). 2020. PMID: 32210076 Free PMC article.

3

4SC-202 as a Potential Treatment for the Pediatric Brain Tumor Medulloblastoma.

Messerli SM, Hoffman MM, Gnimpieba EZ, Kohlhof H, Bhardwaj RD. Messerli SM, et al. Brain Sci. 2017 Nov 3;7(11):147. doi: 10.3390/brainsci7110147. Brain Sci. 2017. PMID: 29099739 Free PMC article.

4

Reduction of Metastasis via Epigenetic Modulation in a Murine Model of Metastatic Triple Negative Breast Cancer (TNBC).

Zylla JLS, Hoffman MM, Plesselova S, Bhattacharya S, Calar K, Afeworki Y, de la Puente P, Gnimpieba EZ, Miskimins WK, Messerli SM. Zylla JLS, et al. Among authors: messerli sm. Cancers (Basel). 2022 Mar 30;14(7):1753. doi: 10.3390/cancers14071753. Cancers (Basel). 2022. PMID: 35406526 Free PMC article.

5

Cisplatin Resistant Spheroids Model Clinically Relevant Survival Mechanisms in Ovarian Tumors.

Chowanadisai W, Messerli SM, Miller DH, Medina JE, Hamilton JW, Messerli MA, Brodsky AS. Chowanadisai W, et al. Among authors: messerli sm, messerli ma. PLoS One. 2016 Mar 17;11(3):e0151089. doi: 10.1371/journal.pone.0151089. eCollection 2016. PLoS One. 2016. PMID: 26986722 Free PMC article.

6

Lactate induces PD-L1 in HRAS^G12V-positive oropharyngeal squamous cell carcinoma.

Verma AK, Messerli SM, Miskimins WK. Verma AK, et al. Among authors: messerli sm. Oncotarget. 2020 Apr 28;11(17):1493-1504. doi: 10.18632/oncotarget.27348. eCollection 2020 Apr 28. Oncotarget. 2020. PMID: 32391119 Free PMC article.

7

Can Anti-Metastatic Albumin-based Superoxide Dismutase Mimetic Serve as a "Moonshot" Drug for Treatment for Brain Tumors - From Medulloblastoma to Glioblastoma?

Hsia CJC, Messerli SM, Miskimins WK. Hsia CJC, et al. Among authors: messerli sm. Cell Biochem Biophys. 2019 Jun;77(2):121-122. doi: 10.1007/s12013-019-00869-2. Epub 2019 May 15. Cell Biochem Biophys. 2019. PMID: 31093886 No abstract available.

8

Use of Antimetastatic SOD3-Mimetic Albumin as a Primer in Triple Negative Breast Cancer.

Messerli SM, Schaefer AM, Zhuang Y, Soltys BJ, Keime N, Jin J, Ma L, Hsia CJC, Miskimins WK. Messerli SM, et al. J Oncol. 2019 Feb 28;2019:3253696. doi: 10.1155/2019/3253696. eCollection 2019. J Oncol. 2019. PMID: 30941174 Free PMC article.

9

Schistosoma mansoni P-glycoprotein levels increase in response to praziquantel exposure and correlate with reduced praziquantel susceptibility.

Messerli SM, Kasinathan RS, Morgan W, Spranger S, Greenberg RM. Messerli SM, et al. Mol Biochem Parasitol. 2009 Sep;167(1):54-9. doi: 10.1016/j.molbiopara.2009.04.007. Epub 2009 May 3. Mol Biochem Parasitol. 2009. PMID: 19406169 Free PMC article.

10

Nitric oxide-dependent changes in Schistosoma mansoni gene expression.

Messerli SM, Morgan W, Birkeland SR, Bernier J, Cipriano MJ, McArthur AG, Greenberg RM. Messerli SM, et al. Mol Biochem Parasitol. 2006 Dec;150(2):367-70. doi: 10.1016/j.molbiopara.2006.08.003. Epub 2006 Aug 28. Mol Biochem Parasitol. 2006. PMID: 16962671 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page